The company's flagship product combines 30 years of microbial expertise with trusted user feedback to produce a next-generation device built to streamline testing, accelerate decisions and strengthen ...
LuminUltra has acquired Source Molecular Corp, a Miami-based provider of testing solutions for microbial source tracking of pathogens. No financial terms were disclosed. Based in Fredericton, New ...
LuminUltra’s new facility at 805 Pinncle in Linthicum Heights unites two previously separate locations for the company’s Technology Development and Distribution divisions. The new location includes ...
LuminUltra, a Canada-based biotechnology leader and portfolio company, recently filed a patent for the first complete, rapid, and on-site COVID-19 wastewater testing solution that will make ...
LuminUltra, the global leader in applied molecular diagnostics, announced the launch of the LuminUltra GeneCount qPCR Corrosion Collection — a complete suite of DNA-based monitoring tools to address ...
The MarketWatch News Department was not involved in the creation of this content. FREDERICTON, NB, Sept. 16, 2025 /PRNewswire/ - LuminUltra, a global leader in applied molecular diagnostics, today ...
FREDERICTON, New Brunswick — LuminUltra ( luminultra.com), the global leader in applied molecular diagnostics, today announced the acquisition of the legionella testing business assets of Genomadix ...
FREDERICTON, NB, Nov. 30, 2020 /CNW/ - Biotechnology front-runner LuminUltra today announced the acquisition of Source Molecular Corporation, a leader in lab-based testing solutions for microbial ...
FREDERICTON, NB, Sept. 27, 2023 /CNW/ - Industry has an effective new tool in its fight against the challenges posed by microbiological activity. LuminUltra, a global leader in applied molecular ...
FREDERICTON, April 15, 2020 /CNW/ - Canadian biotechnology leader LuminUltra today announced that it will provide 500,000 urgently needed COVID-19 tests per week to the Canadian federal government for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results